Pimavanserin Promotes Trophic Factor Release and Protects Cultured Primary Dopaminergic Neurons Exposed to MPP+ in a GDNF-Dependent Manner
Author:
Affiliation:
1. Neuron Experts SAS, F-13015 Marseille, France
2. Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, California 92130, United States
Funder
ACADIA Pharmaceuticals
Publisher
American Chemical Society (ACS)
Subject
Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00751
Reference35 articles.
1. Neurodegeneration, Neuroregeneration, and Neuroprotection in Psychiatric Disorders
2. Neuroprotective effects of the second generation antipsychotics
3. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
4. Genetic clues to the pathogenesis of Parkinson's disease
5. PIMAVANSERIN: POTENTIAL TREATMENT FOR DEMENTIA-RELATED PSYCHOSIS
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats;Frontiers in Neuroscience;2023-08-30
2. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials;Stem Cell Research & Therapy;2023-05-04
3. Molecular Features Triggered by Antipsychotic Medication in Brain Cells;Advances in Experimental Medicine and Biology;2022
4. The protective effects of Pimavanserin against cerebral ischemia-induced brain injury;Bioengineered;2021-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3